These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 23047163

  • 1. Gilenya safety update: cardiac and macula.
    Huggins A, Sergott RC.
    Curr Opin Ophthalmol; 2012 Nov; 23(6):457-9. PubMed ID: 23047163
    [No Abstract] [Full Text] [Related]

  • 2. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    Afshar AR, Fernandes JK, Patel RD, Ksiazek SM, Sheth VS, Reder AT, Hariprasad SM.
    JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
    [No Abstract] [Full Text] [Related]

  • 3. Fingolimod for multiple sclerosis.
    Pelletier D, Hafler DA.
    N Engl J Med; 2012 Jan 26; 366(4):339-47. PubMed ID: 22276823
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
    Komoly S.
    Ideggyogy Sz; 2012 Nov 30; 65(11-12):421-2. PubMed ID: 23289178
    [No Abstract] [Full Text] [Related]

  • 8. Delayed fingolimod-associated asystole.
    Espinosa PS, Berger JR.
    Mult Scler; 2011 Nov 30; 17(11):1387-9. PubMed ID: 21652609
    [Abstract] [Full Text] [Related]

  • 9. Agency is under fire for refusing to supply details of sudden deaths after first dose of multiple sclerosis drug.
    Wise J.
    BMJ; 2012 Feb 23; 344():e1360. PubMed ID: 22362460
    [No Abstract] [Full Text] [Related]

  • 10. Prolonged and symptomatic bradycardia following a single dose of fingolimod.
    Faber H, Fischer HJ, Weber F.
    Mult Scler; 2013 Jan 23; 19(1):126-8. PubMed ID: 22729989
    [Abstract] [Full Text] [Related]

  • 11. Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
    Ward MD, Jones DE, Goldman MD.
    Expert Opin Drug Saf; 2014 Jul 23; 13(7):989-98. PubMed ID: 24935480
    [Abstract] [Full Text] [Related]

  • 12. [Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
    Asensio-Sánchez VM, Trujillo-Guzmán L, Ramoa-Osorio R.
    Arch Soc Esp Oftalmol; 2014 Mar 23; 89(3):104-6. PubMed ID: 24269406
    [Abstract] [Full Text] [Related]

  • 13. New drugs may improve, complicate treatment for multiple sclerosis.
    Link H, Martin R.
    Nat Med; 2010 Mar 23; 16(3):272. PubMed ID: 20208513
    [No Abstract] [Full Text] [Related]

  • 14. Progressive multifocal leukoencephalopathy in a patient taking the MS pill Gilenya.
    Clin Infect Dis; 2013 Oct 23; 57(8):ii. PubMed ID: 24195115
    [No Abstract] [Full Text] [Related]

  • 15. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
    Popova NF.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Oct 23; 111(2 Pt 2):110-3. PubMed ID: 21916166
    [No Abstract] [Full Text] [Related]

  • 16. Oral fingolimod (gilenya) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Dec 29; 52(1353-1354):98-9. PubMed ID: 21344782
    [No Abstract] [Full Text] [Related]

  • 17. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
    Castillo-Trivino T, Lopetegui I, Alarcón-Duque JA, López de Munain A, Olascoaga J.
    J Neurol Neurosurg Psychiatry; 2015 Aug 29; 86(8):931-2. PubMed ID: 25835036
    [No Abstract] [Full Text] [Related]

  • 18. [Fingolimod treatment in multiple sclerosis].
    Tanaka M.
    Nihon Rinsho; 2014 Nov 29; 72(11):2010-4. PubMed ID: 25518386
    [Abstract] [Full Text] [Related]

  • 19. Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
    Tully T, Barkley A, Silber E.
    Neurology; 2015 May 12; 84(19):1999-2001. PubMed ID: 25878178
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
    Széplaki G, Merkely B.
    Ideggyogy Sz; 2012 Nov 30; 65(11-12):369-76. PubMed ID: 23289171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.